Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of H1N1 Vaccines in Children
NCT01161160Phase 2Completed
- Sponsor
- GSK
- Start
- Jul 2010
- Primary completion
- Aug 2010
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines, Cancer Vaccines
- Countries
- 2
01
Overview
A Phase 2 trial of recombinant influenza ha vaccine (h5n1), Q-Pan H1N1 in influenza A H1N1 infection (H1N1), sponsored by GSK. Started Jul 2010; status: completed.
02
Drugs
recombinant influenza ha vaccine (h5n1)Q-Pan H1N1
03
Conditions
influenza A H1N1 infection (H1N1)
Beyond the preview
Go deeper on NCT01161160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01161160.